Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
International Journal of Molecular Sciences · 17.02.2023 · 24 (4) · 4031
DOI: 10.3390/ijms24044031 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.02.2023. Verfasst von Mark Jansen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University Medical Centre Utrecht, Utrecht University, 3584CX Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Myosins, Founder Effect. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development, Hartstichting, UCL Hospitals NIHR Biomedical Research Centre.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disease, commonly caused by pathogenic MYBPC3 variants, and a significant cause of sudden cardiac death. Severity is highly variable, with incomplete penetrance among genotype-positive family members. Previous studies demonstrated metabolic changes in HCM. We aimed to identify metabolite profiles associated with disease severity in carriers of MYBPC3 founder variants using direct-infusion high-resolution mass spectrometry in plasma of 30 carriers with a severe phenotype (maximum wall thickness ≥20 mm, septal reduction therapy, congestive heart failure, left ventricular ejection fraction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, University Medical Centre Utrecht, Utrecht University, 3584CX Utrecht, The Netherlands.
- Netherlands Heart Institute, 3511EP Utrecht, The Netherlands.
- Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, 1081HZ Amsterdam, The Netherlands.
- Department of Cardiology, University Medical Centre Utrecht, Utrecht University, 3584CX Utrecht, The Netherlands.
- Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London WC1E 6DD, UK.
- Department of Genetics, University Medical Centre Groningen, University of Groningen, 9713GZ Groningen, The Netherlands.
ORCID-Profile: Mark Jansen, Maike Schuldt, Beau O van Driel, Jan D H Jongbloed, Ronald H Lekanne Deprez, Judith J M Jans, Jolanda van der Velden, J Peter van Tintelen, Folkert W Asselbergs
Förderung
- Netherlands Organisation for Health Research and Development
- Hartstichting
- UCL Hospitals NIHR Biomedical Research Centre
- Netherlands Cardiovascular Research Initiative: An initiative with the support of the Dutch Heart Foundation
- Dutch Heart Foundation
- Dutch Research Council (NWO)-ZonMW
- ZonMW and Heart Foundation for the translational research program
Zitieren
APA
Jansen, M., Schuldt, M., van Driel, B. O., Schmidt, A. F., Christiaans, I., van der Crabben, S. N., Hoedemaekers, Y. M., Dooijes, D., Jongbloed, J. D. H., Boven, L. G., Deprez, R. H. L., Wilde, A. A. M., Jans, J. J. M., van der Velden, J., de Boer, R. A., van Tintelen, J. P., Asselbergs, F. W., & Baas, A. F. (2023). Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants. International Journal of Molecular Sciences, 24(4), 4031. https://doi.org/10.3390/ijms24044031
Vancouver
Jansen M, Schuldt M, van Driel BO, Schmidt AF, Christiaans I, van der Crabben SN, et al. Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants. International Journal of Molecular Sciences. 2023;24(4):4031. doi:10.3390/ijms24044031
BibTeX
@article{Jansen2023,
author = {Jansen, Mark and Schuldt, Maike and van Driel, Beau O and Schmidt, Amand F and Christiaans, Imke and van der Crabben, Saskia N and Hoedemaekers, Yvonne M and Dooijes, Dennis and Jongbloed, Jan D H and Boven, Ludolf G and Deprez, Ronald H Lekanne and Wilde, Arthur A M and Jans, Judith J M and van der Velden, Jolanda and de Boer, Rudolf A and van Tintelen, J Peter and Asselbergs, Folkert W and Baas, Annette F},
title = {Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4031},
doi = {10.3390/ijms24044031}
}
EUVIMED